Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells

Blood

Volumn 90, Issue 4, 1997, Pages 1649-1655

  Barillé, Sophie ^b   Akhoundi, Camélia ^b   Collette, Madeleine ^b   Mellerin, Marie Paule ^b   Rapp, Marie Josée ^b   Harousseau, Jean Luc ^b   Bataille, Régis ^b   Amiot, Martine ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; COLLAGENASE; CYTOKINE; ENZYME PRECURSOR; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; ONCOSTATIN M; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

EID: 0030744830     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1649     Document Type: Article

References (41)

1. Bataille R, Chappard D, Basle MF: Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy. A prospective study of 87 bone biopsies. Blood 87:4762, 1996
2. Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, Alexandre C: Mechanisms of bone destruction in multiple myeloma: The importance of an unbalanced process in determining the severity of lylic bone disease. J Clin Oncol 7:1909, 1989
3. Witzig T, Dhodapkar M, Kyle R, Greipp P: Quantification of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108, 1993
4. Witzig T, Gertz MA, Lust JA, Kyle RA, O'Fallon W, Greipp P: Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood 88:1780, 1996
5. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145, 1991
6. Kleiner D, Stetler-Stevenson W: Structural biochemistry and activation of matrix metalloproteinases. Curr Opin Cell Biol 5:891, 1993
7. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 14:455, 1992
8. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:361, 1994
9. Meikle MC, Bord S, Hembry RM, Compston J, Croucher PI, Reynolds JJ: Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci 103:1093, 1992
10. Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA, MacElroy A, Menius AJ, Jeffreys JJ, Clark RL, MacGeehan GM, Connolly KM: Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 182:449, 1995
11. Hill PA, Docherty AJP, Bottomley KMK, O'Connell JP, Morphy R, Reynolds JJ, Meikle MC: Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 308:167, 1995
12. Brown P, Bloxidge R, Stuart N, Gatter K, Carmichael DF: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small cell lung carcinoma. J Natl Cancer Inst 85:574, 1993
13. Bernhard E, Gruber S, Muschel R: Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 91:4293, 1994
14. Ray J, Stetler-Stevenson W: Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 14:908, 1995
15. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379, 1995
16. Uchiyama H, Barut BA, Mohrbacher AF, Chauhan D, Anderson KC: Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood 82:3712, 1993
17. Lokhorst HM, Lamme T, de Smet M, Klein S, de Weger RA, van Oers R, Bloem AC: Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood 84:2269, 1994
18. Barillé S, Collette M, Bataille R, Amiot M: Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood 86:3151, 1995
19. Zhang XG, Gaillard JP, Robillard N, Lu ZY, Gu ZJ, Jourdan M, Boiron JM, Bataille R, Klein B: Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83:3654, 1994
20. 3 derivative in association with dexamethasone. Blood 88:4659, 1996
21. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196, 1980
22. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R: Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood 73:517, 1989
23. Nishimoto N, Ogata A, Shima Y, Tani Y, Ogawa H, Nakagawa M, Sugiyama H, Yoshizaki K, Kishimoto T: Oncostatin M, leukemia inhibitory factor, and interleukin-6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J Exp Med 179:1343, 1994
24. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B: Ciliary neurotrophic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 177:1337, 1994
25. Klein B, Bataille R: Cytokine network in human multiple myeloma. Hematol Oncol Clin North Am 6:273, 1992
26. Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu JJ, Morel-Fournier B, Harousseau JL, Bataille R, Rossi JF, Klein B: Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood 85:2521, 1995
27. Urashima M, Ogata A, Chauban D, Hatziyanni M, Vidriales M, Dedera D, Schlossman, Anderson K: Transforming growth factor-β1: Differential effects on multiple myeloma versus normal B cells. Blood 87:1928, 1996
28. Juge-Morineau N, François S, Puthier D, Godard A, Bataille R, Amiot M: The gp130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the antiproliferative effect of dexamethasone on human myeloma cells. Br J Haematol 90:707, 1995
29. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumari K, Taga T, Kishimoto T, Suda T: Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90:11924, 1993
30. Manolagas SC: Role of cytokines in bone resorption. Bone 17:63S, 1995
31. Crawford HC, Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14:234, 1994
32. Bernhard EJ, Muschel RJ, Hughes EN: Mr 92,000 Gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50:3872, 1990
33. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI: Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts, synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 265:17238, 1990
34. Rifas L, Fausto A, Scott MJ, Avioli LV, Welgus H: Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: Differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology 134: 213, 1993
35. Huhtala P, Chow LT, Tryggvason K: Structure of the human type IV collagenase gene. J Biol Chem 265:11077, 1990
36. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P: Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189, 1990
37. D'Armiento J, Dalal SS, Okada Y, Berg RA, Chada K: Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71:955, 1992
38. Stetler-Stevenson WG: Progelatinase A activation during tumor cell invasion. Invasion Metastasis 14:259, 1994
39. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y: Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56:2707, 1996
40. Brown PD, Giavazzi R: Matrix metalloproteinase inhibition: A review of anti-tumour activity. Ann Oncol 6:967, 1995
41. Hodgson J: Remodeling MMPIs. Biotechnology 13:554, 1995